Feature
Components
|
Components No. |
Name |
10628ES10
|
10628ES60
|
|
10628 |
Hieff T7 RNA Polymerase (low dsRNA, 250 U/μL) |
40 μL |
400 μL |
[Note]: T7 RNA Polymerase can be used in combination with 10× Transcription Buffer 3 (Cat#10674).
|
Source |
Recombinant E. coli with T7 RNA Polymerase gene |
|
Optimum Temperature |
37℃ |
|
Storage Buffer |
50 mM Tris-HCl, 1 mM EDTA, 10 mM DTT, 100 mM NaCl, 0.1% Triton X-100,50% (v/v) glycerin,pH7.9 at 25℃ |
|
Unit Definition |
The amount of enzyme required to incorporate 1 nmol of [3H] GMP into the acid-insoluble precipitate within 1 hour at 37°C and pH 8.0 is defined as 1 unit. |
|
Recommended Mg2+ |
30mM Magnesium Acetate |
|
Items |
Specification/Standard |
|
Enzyme activity |
250-300U/μL |
|
Protein Purity |
≥95% |
|
Endotoxin |
<20 EU/mg |
|
Protease |
Negative |
|
Exonuclease |
Negative |
|
Nickase |
Negative |
|
RNase |
Negative |
|
E.coli host protein |
<50ppm |
|
E.coli host DNA |
<10 fg/U |
|
Mycoplasma examination |
Negative |
|
T7 RNA Polymerase |
Yield(mg/mL) |
mRNA Integrity(%) |
dsRNA content (%) |
|
WT T7 |
9.5 |
81.9 |
0.29% |
|
Low dsRNA T7 |
9.0 |
82 |
0.0037% |

Figure 2. Evaluation of the immunogenicity of the IVT products in murine RAW264.7 cells (Figures 2A and 2B). IFN-β mRNA and protein levels were reduced in RAW264.7 cells transfected with mRNA produced by mutants compared to wild-type, indicating that mRNA synthesized by the wild-type T7 RNAP elicited the strongest immune response, while mRNA from the mutants showed a significantly reduced response.

Figure 3. The dsRNA content in mRNA synthesized with Hieff™ T7 RNA polymerase is lower than that in mRNA synthesized with the wild-type enzyme after cellulose treatment.
The products are shipped with dry ice and can be stored at -15℃ ~ -25℃ for one year.


